The company statements in my opinion are quite confusing and lacking in detail. They do not specify what the reason for the extra testing in the statement to the ASX. . Then they suddenly announce a strategy to develop a new battery system in 2024 at the same presentation.
Ann: Update on Submission of Final Module to FDA, page-28
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $363.5M | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | 99.0¢ | 96.0¢ | $240.1K | 246.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 400 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.5¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| EBR (ASX) Chart |